Organization: SkyePharma plc

SkyePharma buys equity stake in RPT Pharma

UK-based SkyePharma plc has acquired a 40.2% interest in RTP Pharma Inc for US$20 million and has participated in a $15-million equity infusion to fund ongoing operations. The involvement of SkyePharma will assist the Montreal-based firm in expanding its market position through strategic project collaboration and access to Skye’s expertise in controlled release and inhalation…